Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Preferred Shares (2020 - 2022)

Historic Preferred Shares for Spero Therapeutics (SPRO) over the last 3 years, with Q2 2022 value amounting to $2000.0.

  • Spero Therapeutics' Preferred Shares fell 3333.33% to $2000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $2000.0, marking a year-over-year decrease of 3333.33%. This contributed to the annual value of $3000.0 for FY2021, which is 0.0% changed from last year.
  • Latest data reveals that Spero Therapeutics reported Preferred Shares of $2000.0 as of Q2 2022, which was down 3333.33% from $3000.0 recorded in Q1 2022.
  • Spero Therapeutics' Preferred Shares' 5-year high stood at $3000.0 during Q3 2020, with a 5-year trough of $2000.0 in Q2 2022.
  • Its 3-year average for Preferred Shares is $2875.0, with a median of $3000.0 in 2020.
  • Its Preferred Shares has fluctuated over the past 5 years, first changed by 0.0% in 2021, then tumbled by 3333.33% in 2022.
  • Quarter analysis of 3 years shows Spero Therapeutics' Preferred Shares stood at $3000.0 in 2020, then changed by 0.0% to $3000.0 in 2021, then crashed by 33.33% to $2000.0 in 2022.
  • Its last three reported values are $2000.0 in Q2 2022, $3000.0 for Q1 2022, and $3000.0 during Q4 2021.